KRAVICZ MARCELO HENRIQUE

Iannone, M., Kravicz, M., Rainone, P., Antoniou, A., Stucchi, S., Valtorta, S., et al. (2025). Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1566257]. Dettaglio

Persico, A., Molteni, L., Mantecca, P., Kravicz, M., Bragato, C. (2025). Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-00258-1]. Dettaglio

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio

Molteni, L., Persico, A., Kravicz, M., Antoniou, A., Peqini, K., Mantecca, P., et al. (2025). REDUCING PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY VIA LIPOSOMAL DRUG TARGETING. In Proceedings of the 35th National Conference of the Italian Group for the Study of Neuromorphology “Gruppo Italiano per lo Studio della Neuromorfologia” G.I.S.N. (pp.25-25). Dettaglio

Molteni, L., Bragato, C., Persico, A., Nicolini, G., Re, F., Mantecca, P., et al. (2025). Targeted Paclitaxel Delivery Via Metalloproteinase-Sensitive Liposomes To Prevent Peripheral Neurotoxicity: A Proof Of Concept. Intervento presentato a: 2025 PERIPHERAL NERVE SOCIETY ANNUAL MEETING - 17-20 May 2025, Edimburgo, UK. Dettaglio